SCHEMBL7423302

SCHEMBL7423302

CC(C)[C@H](NC(=O)CNS(C)(=O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(F)(F)CCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.52
HTRA1 Q92743 7/20 0.40
CASP3 P42574 1/20 0.39
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CTSF Q9UBX1 1/20 0.38
ELANE P08246 2/20 0.38
CTSD P07339 2/20 0.37
ACE P12821 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7415572 0.87 CASP1 (0.54) CASP1HTRA1CASP3CTSBCTSD
SCHEMBL7423261 0.84 ELANE (0.47) CASP1HTRA1CASP3ELANECTSD
SCHEMBL7410781 0.83 CASP1 (0.52) CASP1CASP3CTSLCTSBELANE
SCHEMBL7419381 0.79 CASP1 (0.48) CASP1CASP3CTSLCTSBELANE
SCHEMBL7419148 0.77 CTSL (0.49) CASP1CTSLCTSBELANE
SCHEMBL7411626 0.77 CASP1 (0.47) CASP1CASP3ELANE
SCHEMBL7410782 0.75 CASP1 (0.48) CASP1HTRA1ELANE
SCHEMBL9578947 0.75 CA2 (0.47) CASP1HTRA1CASP3CTSD
SCHEMBL9579040 0.74 CASP3 (0.46) CASP1CASP3CTSLCTSBELANE
SCHEMBL7413833 0.74 CASP1 (0.47) CASP1CTSLCTSBELANECTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992017176-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1992-10-15 WO claimed
US-5256677-A Enzyme inhibitor for treating acquired immune deficiency syndrome ABBOTT LABORATORIES (US) 1993-10-26 US disclosed
WO-1992017176-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1992-10-15 WO disclosed
US-5151438-A Enzyme inhibitors for treatment of aids ABBOTT LABORATORIES (US) 1992-09-29 US disclosed